TASK

🇺🇸 USA (FDA)

Pre-market Approval (PMA) or 510(k):
The FDA classifies contact lenses primarily under Class II (daily wear lenses) and Class III (extended wear or therapeutic lenses). The 510(k) Premarket Notification is the most common process for Class II devices, where manufacturers must prove that their device is substantially equivalent to an already-approved device. However, Class III devices like therapeutic lenses typically require Premarket Approval (PMA), a more rigorous process.

• 510(k) Submission:

  • Statistics: As of 2021, the FDA processed approximately 3,500 510(k) submissions annually, with a clearance rate of over 90%.

  • Requirements: To submit a 510(k), manufacturers need to demonstrate that their contact lens is substantially equivalent to a legally marketed device in terms of safety, effectiveness, and intended use.

  • Testing: Bench testing (e.g., material strength, hydration properties) and clinical data (e.g., wearability, user comfort) are essential.

  • FDA Review Process: The FDA typically reviews a 510(k) submission within 90 days, but this can vary based on the complexity of the device.

• PMA Submission

  • Statistics: About 15-20 new Class III devices (including lenses) are approved annually through the PMA process.

  • Requirements: For Class III devices, the manufacturer must provide extensive clinical data proving safety and effectiveness. This includes human clinical trials that assess both the long-term wear of the lenses and potential adverse effects like corneal irritation, infection, and hypoxia (lack of oxygen to the eye).

  • Approval Time: PMA approval typically takes 1-3 years, depending on the complexity and submission completeness.

The FDA also requires labeling that includes warnings for extended wear lenses, particularly highlighting risks such as corneal ulcers, infection, and other serious eye conditions. FDA 510(k) Database and the FDA Premarket Approval Database are crucial tools for manufacturers to track submissions.

🇪🇺 Europe (EU MDR)

Conformity Assessment and CE Marking:
Under the EU MDR 2017/745, contact lenses are typically classified as Class IIa for daily wear and Class IIb or Class III for extended or therapeutic lenses, depending on the intended use and the duration of wear. Manufacturers must obtain a CE Mark through a conformity assessment to legally market their devices within the EU.

• Conformity Assessment Process:

  • CE Marking Process: The first step is the submission of a technical file or design dossier to a Notified Body (NB), a third-party organization accredited to assess conformity.

  • Clinical Evaluation Report (CER): A CER is required, providing evidence that the device complies with the General Safety and Performance Requirements (GSPR) outlined in Annex I of the MDR. This includes evaluations of biocompatibility, wear comfort, oxygen permeability, and long-term safety.

  • Statistics: Approximately 500-700 devices are CE marked annually in the Class IIa and Class IIb categories, with an increasing number of devices going through the Class III process due to evolving EU regulations.

  • Clinical Trials: For Class IIb and Class III lenses (e.g., therapeutic lenses), clinical trials are mandatory to assess long-term safety, infection control, and complications like hypoxia or corneal neovascularization.

  • Review Time: The CE marking process can take 6-12 months for Class IIa and 12-24 months for Class IIb/III devices, depending on the complexity of the device and the completeness of the submitted data.

The Notified Body is responsible for reviewing the risk management procedures, product specifications, and ensuring compliance with the ISO 13485 standard (Quality Management Systems). Manufacturers must also conduct post-market clinical follow-up (PMCF) to monitor long-term safety after device approval.

🇮🇳 India (CDSCO)

Regulatory Pathway and CDSCO Approval:
In India, contact lenses are classified as Class C (daily wear lenses) or Class D (extended wear or therapeutic lenses) under the Medical Device Rules 2017 (MDR 2017). The process for approval involves submitting a detailed registration dossier to the Central Drugs Standard Control Organization (CDSCO).

• Submission Process:

  • Registration Dossier: Manufacturers must submit a technical dossier including details on the device’s materials, safety tests, and clinical data demonstrating the lens's performance. The dossier must also cover biocompatibility and product labeling.

  • Testing and Certification: Manufacturers must comply with ISO 13485, and conduct clinical trials as per Schedule I of the Medical Device Rules. For therapeutic lenses, this may include trials for ocular health, infection prevention, and lens durability.

  • Clinical Trials: India-specific data may be required, especially for new devices or for those that are imported. Clinical trials may assess the biocompatibility, wearability, and adverse reactions to lenses under Indian conditions.

  • Approval Time: Approval times in India vary significantly, but typically it takes 6 months to 1 year for Class C devices, and 1 to 2 years for Class D devices, depending on the data completeness and clinical requirements.